About Prime Medicine, Inc. 
Prime Medicine, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 41 Schemes (20.05%)
Foreign Institutions
Held by 69 Foreign Institutions (8.94%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2026)
Net Profit:
-42 Million
Pharmaceuticals & Biotechnology
USD 610 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.40
-166.77%
5.05






